✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Overall disease activity was measured by the SLAM score.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:High dose intravenous immunoglobulins (IVIG) have become an important treatment modality for some immune mediated diseases.
📊
Key Findings & Data:Eight patients with active renal involvement disease (all of them female, mean age; 25.8 ± 8.1, mean disease duration; 30.5 ± 16.1 months) were given 400 mg/kg/day 4. generation IVIG preparation (Octagam.
💡
Conclusion & Impact:Overall disease activity was measured by the SLAM score.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
High dose intravenous immunoglobulins (IVIG) have become an important treatment modality for some immune mediated diseases. We investigated the effect of high dose IVIG in systemic lupus erythematosus (SLE). Eight patients with active renal involvement disease (all of them female, mean age; 25.8 ± 8.1, mean disease duration; 30.5 ± 16.1 months) were given 400 mg/kg/day 4. generation IVIG preparation (Octagam. Octapharma, Pharmazeutika Wien, Austria) during the days 1 to 5 and 21 to 25. Overall disease activity was measured by the SLAM score. The measured systemic lupus activity was declined from 19.0 to 4.38 (p
🔖
Cite This Article
KINIKLI, G., KESKİN, G., TURGAY, M., TOKGÖZ, G., DUMAN, M. (2022). High dose intravenous immunoglobulin (IVIG) treatment in patients with lupus nephritis. Journal of Ankara Medical School, Cilt: 20 - Sayı: 2, 95–98. https://ajindex.com/articles/560101